Institution

Odense University Hospital

Odense, DenmarkWebsite

Also known as: Odense Universitets Hospital · OUH

386running trials
160closed trials
39,080publications (OpenAlex)

Running trials

Not yet recruiting
BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
NCT07474961· Phase 4· Anne Louise Tølbøll Sørensen· Source
Not yet recruiting
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
NCT07915219· Phase 3· Boehringer Ingelheim· Source
Not yet recruiting
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
NCT07291102· Phase 3· Nationwide Children's Hospital· Source
Not yet recruiting
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
NCT07441408· Phase 3· Bristol-Myers Squibb· Source
Not yet recruiting
Dose-Escalated Short-Course Proton Therapy for Locally Advanced Rectal Cancer
NCT07903883· University of Aarhus· Source
Not yet recruiting
Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study
NCT07634263· Odense University Hospital· Source
Not yet recruiting
Home-based Exercise for Improving Health-related Quality of Life in Systemic Sclerosis
NCT07840430· University of Aarhus· Source
Recruiting
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-OLE).
2026-526139-20-00· Phase 3· Kardigan Inc.· Source
Recruiting
The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial
NCT07442357· Copenhagen University Hospital, Rigshospitalet· Source
Not yet recruiting
Immunoprofiling of the Patient Tumor Microenvironment in BCMA Targeted Therapies
NCT07878208· Odense University Hospital· Source
Recruiting
DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease
NCT07795398· Phase 4· Odense University Hospital· Source
Recruiting
A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.
NCT01491815· Phase 4· Karolinska Institutet· Source
Recruiting
A clinical trial to learn about the effects of JFI447 and how it shows up in scans compared to FFG233 in people with solid tumors
2025-523665-24-00· Phase 1· Novartis Pharma AG· Source
Not yet recruiting
Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy - ILLUMINATE
NCT07870681· Phase 2/3· Oslo University Hospital· Source
Not yet recruiting
bNAbs and Anti-PD-1 in HIV
NCT07820813· Phase 2· Ole Schmeltz Søgaard· Source
Recruiting
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
2025-525009-18-00· Phase 3· Incyte Corp.· Source
Not yet recruiting
Effects of semaglutide as add-on therapy to sulfonylurea on plasma glucose in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SEMA)
2025-523414-89-00· Phase 2· Steno Diabetes Center Copenhagen· Source
Recruiting
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
NCT07476729· Phase 3· Charite University, Berlin, Germany· Source
Not yet recruiting
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.
NCT07757412· Phase 2· Odense University Hospital· Source
Not yet recruiting
Rapid or Ultra-rapid Diagnosis of Myocardial Infarction Using High-Sensitivity Cardiac Troponin on Hospital Presentation
NCT07727135· Herlev and Gentofte Hospital· Source
Recruiting
Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer
NCT07432802· Aarhus University Hospital· Source
Recruiting
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07771465· Phase 3· Kardigan, Inc.· Source
Not yet recruiting
A phase II randomised trial investigating the benefit of adjuvant immunotherapy after neoadjuvant chemoimmunotherapy for resectable NSCLC (ADIL)
2025-524439-38-00· Phase 2· Oslo Universitetssykehus HF· Source
Not yet recruiting
Family TIME: A Family-focused Nursing Intervention for Adults Receiving Haemodialysis and Their Families
NCT07801937· University of Southern Denmark· Source
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087· Phase 3· Boehringer Ingelheim· Source
Recruiting
CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)
NCT07646977· Odense University Hospital· Source
Recruiting
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
2026-525234-39-00· Phase 1· Janssen Cilag International· Source
Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
NCT07544654· Phase 3· Boehringer Ingelheim· Source
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
NCT07662109· Phase 3· AstraZeneca· Source
Not yet recruiting
BEAT Fatigue
2024-519268-41-00· Phase 4· Odense University Hospital· Source
Recruiting
STRATIFY II
2024-515712-45-00· Phase 4· Rigshospitalet· Source
Recruiting
Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
NCT06453876· Phase 3· Jesper Kjaergaard· Source
Recruiting
Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer?
NCT07733505· Phase 1· Odense University Hospital· Source
Not yet recruiting
MR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)
NCT07635108· Odense University Hospital· Source
Not yet recruiting
The MAYA2 trial
2025-521941-25-00· Phase 2· Odense University Hospital· Source
Recruiting
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
2025-521590-13-00· Phase 3· Janssen Cilag International· Source
Recruiting
Study of GVV858 as a single agent or in combination with endocrine therapy in patients with HR+/HER2- breast cancer and other advanced solid tumors
2025-521911-38-00· Phase 1/2· Novartis Pharma AG· Source
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
Vascular Complications After Kidney Transplantation
NCT07531966· University of Aarhus· Source
Recruiting
A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
2025-521702-18-00· Phase 1· Novartis Pharma AG· Source
Recruiting
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
NCT07570173· Phase 2/3· Merck Sharp & Dohme LLC· Source
Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001· Phase 3· Novo Nordisk A/S· Source
Recruiting
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
2025-521546-23-00· Phase 3· Novartis Pharma AG· Source
Recruiting
Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
NCT07478003· Phase 3· Thomas Engstrom· Source
Recruiting
Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir (The INITIATE Study)
NCT07481175· Phase 1· Thomas Aagaard Rasmussen· Source
Recruiting
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
NCT07489495· Phase 3· Merck Sharp & Dohme LLC· Source
Recruiting
Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI)
NCT07511283· Odense University Hospital· Source
Recruiting
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
2025-522338-30-00· Phase 2· Eli Lilly & Co.· Source
Enrolling by invitation
Women With Previous GDM and the Effects of HIIT.
NCT07566845· Odense University Hospital· Source
Recruiting
A Randomized, placebo-controlled, double-blinded Phase 2 Trial of Dapagliflozin for Preventing Treatment-associated Cardiotoxicity in Lymphoma
2025-521205-41-00· Phase 2· Aalborg University Hospital· Source

Showing 50 of 386.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Childhood cancers27 recruiting
Colorectal cancer20 recruiting
Lung cancer18 recruiting
Crohn's disease10 recruiting
Heart failure10 recruiting
Prostate cancer10 recruiting
Coronary artery disease9 recruiting
Multiple myeloma9 recruiting
Acute myeloid leukaemia8 recruiting
Atrial fibrillation8 recruiting
Chronic lymphocytic leukaemia8 recruiting
Endometrial cancer8 recruiting
Acute lymphoblastic leukaemia7 recruiting
Ovarian cancer7 recruiting
Chronic kidney disease6 recruiting
Pancreatic cancer6 recruiting
Stroke6 recruiting
Ulcerative colitis6 recruiting
Bronchiectasis5 recruiting
Metastatic breast cancer5 recruiting
Type 1 diabetes5 recruiting
Aortic stenosis4 recruiting
Bladder cancer4 recruiting
Cervical cancer4 recruiting
Dilated cardiomyopathy4 recruiting
High blood pressure4 recruiting
Osteoporosis4 recruiting
Polymyalgia rheumatica4 recruiting
Rheumatoid arthritis4 recruiting
Sarcoidosis4 recruiting
Type 2 diabetes4 recruiting
Deep vein thrombosis and pulmonary embolism3 recruiting
Follicular lymphoma3 recruiting
Giant cell arteritis3 recruiting
Glioblastoma3 recruiting
Kidney cancer3 recruiting
Myelodysplastic syndromes3 recruiting
Chronic myeloid leukaemia2 recruiting
CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
COPD2 recruiting
Diffuse large B-cell lymphoma2 recruiting
Familial hypercholesterolaemia2 recruiting
Gestational diabetes2 recruiting
HIV2 recruiting
Hypertrophic cardiomyopathy2 recruiting
Idiopathic pulmonary fibrosis2 recruiting
Liver and biliary tract cancer2 recruiting
Lupus (SLE)2 recruiting
Mantle cell lymphoma2 recruiting
Multiple sclerosis2 recruiting
Obesity2 recruiting
Psoriasis2 recruiting
Psoriatic arthritis2 recruiting
Systemic sclerosis (scleroderma)2 recruiting
Triple-negative breast cancer2 recruiting
Amyloidosis1 recruiting
ANCA-associated vasculitis1 recruiting
Ankylosing spondylitis1 recruiting
Brain metastases1 recruiting
Chronic rhinosinusitis with nasal polyps1 recruiting
Cystic fibrosis1 recruiting
Dermatomyositis and polymyositis (myositis)1 recruiting
Epilepsy1 recruiting
Fatty liver disease (MASLD/MASH)1 recruiting
Gastric and oesophageal cancer1 recruiting
Glaucoma1 recruiting
Head and neck cancer1 recruiting
Hepatitis B1 recruiting
Hodgkin lymphoma1 recruiting
Huntington's disease1 recruiting
Immune thrombocytopenia (ITP)1 recruiting
Liver cirrhosis1 recruiting
Lyme disease1 recruiting
Melanoma1 recruiting
Meningioma1 recruiting
Neuroblastoma1 recruiting
Neuroendocrine tumours1 recruiting
Parkinson disease1 recruiting
Polycystic ovary syndrome1 recruiting
Sarcoma1 recruiting
Thalassaemia1 recruiting
Ventricular tachycardia1 recruiting

Closed trials

Active, not recruiting
Study of zoldonrasib in Previously Treated Patients with RAS G12D-Mutant Non-Small Cell Lung Cancer (NSCLC)
2025-521681-10-00· Phase 2· Revolution Medicines Inc.· Source
Active, not recruiting
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
NCT06931405· Phase 2· Blueprint Medicines Corporation· Source
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
NCT06747949· Phase 3· Amgen· Source
Completed
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
NCT06797869· Phase 2· Novo Nordisk A/S· Source
Recruiting
Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
NCT06613009· Phase 1· Innovent Biologics (Suzhou) Co. Ltd.· Source
Completed
Melatonin fOr CHronic bAck Pain (The MOCHA Trial)
NCT06476392· Phase 3· Odense University Hospital· Source
Completed
ARETHA: cARdiomems vEriciguaT Heart fAilure (A double-blind randomized placebo-controlled trial of vericiguat in heart failure patients with CardioMEMS™ HF System)
2024-514111-10-00· Phase 4· Rigshospitalet· Source
Recruiting
Effect Camostat for Kidney Protection in Chronic Kidney Disease
NCT06794593· Phase 2· Odense University Hospital· Source
Terminated
Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Everolimus-eluting Stents
NCT06718179· Phase 4· Odense University Hospital· Source
Completed
Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease
NCT06421597· Phase 2· Odense University Hospital· Source
Completed
Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease (RIGID
2023-506949-27-00· Phase 2· Odense University Hospital· Source
Completed
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis
2023-510249-79-00· Phase 2· Boehringer Ingelheim International GmbH· Source
Completed
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
NCT06335303· Phase 2· Boehringer Ingelheim· Source
Completed
A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations
NCT06529419· Phase 2· AstraZeneca· Source
Completed
A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome
2023-503923-24-00· Phase 3· Horizon Therapeutics Ireland Designated Activity Company· Source
Completed
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)
2023-506185-31-00· Phase 2/3· Pliant Therapeutics Inc.· Source
Completed
FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: A pilot study for a randomized clinical trial (MONITOR-PILOT)
2023-506550-20-00· Phase 2/3· Odense University Hospital· Source
Recruiting
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
NCT06311682· Phase 3· LEO Pharma· Source
Completed
Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents
NCT06299722· Aalborg University· Source
Recruiting
Platform Clinical Study for Conquering Scleroderma
NCT06195072· Phase 2· Scleroderma Research Foundation, Inc.· Source
Completed
Long-term Monitoring of Sleep with Ear-EEG in Patients with Chronic Pain
NCT06368531· Odense University Hospital· Source
Completed
A Study of Tobemstomig/RO7247669 Combined with Nab-Paclitaxel Compared with Pembrolizumab Combined with Nab-Paclitaxel in Participants with Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
2022-502457-34-00· Phase 2· F. Hoffmann-La Roche AG· Source
Completed
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
NCT06169397· Phase 2· Xentria, Inc.· Source
Completed
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
NCT05901831· Phase 3· Bayer· Source
Completed
GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer
2022-502453-33-00· Phase 2· Genmab A/S· Source
Completed
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis
NCT06280391· Phase 2· Sanofi· Source
Completed
A study to investigate the effect of different doses of AZD0780 on low-density lipoprotein cholesterol (LDL-C) levels compared with placebo and its safety and tolerability in participants 18 to 75 years of age with dyslipidemia
2023-506197-12-00· Phase 2· Astrazeneca AB· Source
Completed
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity
NCT06104124· Phase 3· Amgen· Source
Recruiting
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
NCT06285318· Janssen-Cilag Ltd.· Source
Completed
A first-in-human trial of safety and efficacy of GEN3017 in subjects with Hodgkin lymphoma or non-Hodgkin lymphoma
NCT06018129· Phase 1/2· Genmab A/S· Source
Completed
A Study to Evaluate Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants with Relapsed or Refractory Multiple Myeloma
2023-503689-21-00· Phase 1/2· F. Hoffmann-La Roche AG· Source
Completed
Subcutaneous immunoglobulin (HyQvia) against early infections in multiple myeloma: SHIELD
2023-505053-40-00· Phase 2· Lillebaelt Hospital· Source
Completed
Observational Bronchoscopy Video Data Collection Study With Adult Patients
NCT06465797· Ambu A/S· Source
Completed
A clinical trial to assess the safety and effects of AGMB-129 compared to placebo in patients with fibrostenotic Crohn’s disease.
2022-502789-26-01· Phase 2· Agomab Spain S.L.U.· Source
Active, not recruiting
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
NCT06045806· Phase 3· Celgene· Source
Terminated
A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382
NCT06032546· Phase 2· AbbVie· Source
Completed
What Matters to Patients With Severe Hip or Knee Osteoarthritis?
NCT05972525· Vejle Hospital· Source
Completed
Phase II, multi‑cohort trial of neoadjuvant and post‑surgery IO102‑IO103 and pembrolizumab in patients with selected resectable tumors
2022-502787-20-00· Phase 2· IO Biotech ApS· Source
Completed
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
NCT06065540· Phase 3· Novo Nordisk A/S· Source
Completed
Senolytics to Improve Osteoporosis Therapy
NCT06018467· Phase 2· Odense University Hospital· Source
Completed
Upfront Ultrasound for Preoperative Localization in Primary Hyperparathyroidism
NCT07068867· Odense University Hospital· Source
Completed
The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial
NCT05758779· Odense University Hospital· Source
Active, not recruiting
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
NCT06081894· Phase 3· Cytokinetics· Source
Completed
Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
2022-502196-31-00· Phase 2/3· Kartos Therapeutics Inc.· Source
Completed
The RADIAL study: A clinical trial to learn more about the benefits and the acceptability of trials that include technology to centre the trial around the participant, known as decentralised, and hybrid clinical trials compared to standard clinical trials that take place in hospitals or in research centres, in patients with type 2 diabetes mellitus treated with Toujeo®, a drug to help manage blood sugar levels.
2022-500449-26-00· Phase 4· University Medical Center Utrecht· Source
Completed
STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
NCT05843578· Phase 2· Agomab Spain S.L.U.· Source
Active, not recruiting
A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT05942222· Phase 4· Copenhagen University Hospital, Rigshospitalet· Source
Completed
A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT06087289· Phase 1/2· Novakand Pharma AB· Source
Completed
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon)
2022-501538-44-00· Phase 3· Amgen Inc.· Source
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

Showing 50 of 160.

Registry name variants (75)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Odense University Hospital
Odense C, 5000
324 trials
Odense University Hospital
Odense, 5000
139 trials
Odense University Hospital
Svendborg, 5700
22 trials
Department of Oncology, Odense University Hospital
Odense, 5000
6 trials
Department of Cardiology, Odense University Hospital
Odense, 5000
4 trials
Department of Endocrinology, Odense University Hospital
Odense, 5000
4 trials
Department of Urology, Odense University Hospital
Odense, 5000
3 trials
- NCT06709196Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
  Contact: Lars Lund, Prof, MD, DMSci
- NCT05223491En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
- NCT04079699Predicting Prostate Cancer in Elderly Men
Department of Obstetrics and Gynaecology, Odense University Hospital
Odense, 5000
2 trials
- NCT07400835Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding
  Contact: Lone K. Petersen, MD, dr.med
- NCT06846775The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study
  Contact: Lone K. Petersen, MD, dr.med
Department of Paediatrics and Adolescent Medicine, Odense University Hospital
Odense, Odense C 5000
2 trials
- NCT06367725Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density
  Contact: Mathias Rathe, phd
- NCT05376566Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections
Department of Respiratory Medicine, Odense University Hospital
Odense, 5000
2 trials
- NCT07460999Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)
  Contact: Christian Borbjerg Laursen, Professor, PhD, MD
- NCT06848738Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound
Odense Universitetshospital (Ouh) (Odense University Hospital)
Odense C, 05000
2 trials
- NCT03126019A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
- NCT03235544A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor
Odense University Hospital
Nyborg, 5800
2 trials
- NCT06788340MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
- NCT05243797Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Odense University Hospital - Department of Cardiology
Odense, 5000
2 trials
- NCT03129490The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
- NCT03129555The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
Odense University Hospital - Department of Emergency Medicine
Odense, 5000
2 trials
- NCT03129490The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
- NCT03129555The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
Odense University Hospital - Department of Geriatrics
Odense, 5000
2 trials
- NCT03129490The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
- NCT03129555The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
Odense University Hospital - Department of Neurology
Odense, 5000
2 trials
- NCT03129490The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
- NCT04032379Diagnostic and Prognostic Biomarkers of Idiopathic Intracranial Hypertension
  Contact: Dagmar Beier, M.D., Ph.D.
Odense University Hospital - Odense
Odense, 5000
2 trials
- NCT07771465A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
  Contact: Kardigan Clinical Trial Team
- NCT07210723A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
  Contact: Kardigan Clinical Trial Team
Pain Center, Department of Anesthesiology and Intensive Care Medicine, University Hospital Odense
Odense, 5000
2 trials
- NCT06361914Digital CBT-I for Patients With Chronic Pain and Insomnia
- NCT06368531Long-term Monitoring of Sleep with Ear-EEG in Patients with Chronic Pain
Steno Diabetes Center Odense, Odense University Hospital
Odense, Odense C 5000
2 trials
- NCT07566845Women With Previous GDM and the Effects of HIIT.
- NCT07240012Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes
  Contact: Lene Ringholm Chief physician, PhD, Associate Professor
Departement of Cardiology, Odense University Hospital
Odense C, 5000
1 trial
- NCT05614219Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
  Contact: Finn Lund Henriksen, MD
Department of Endocrinology and Metabolism, Odense University Hospital
Odense
1 trial
- NCT01611896Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism
Department of Gastroenterology and Hepatology, Odense University Hospital
Odense, 5000
1 trial
- NCT03308916Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
  Contact: Maja Thiele, MD, PhD
Department of Gynecology and Obstetrics, Odense University Hospital
Odense, Odense C 5000
1 trial
- NCT07240012Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes
  Contact: Lene Ringholm Chief physician, PhD, Associate Professor
Department of Infectious Diseases, Odense University Hospital
Odense, 5100
1 trial
- NCT03418441Central Nervous System Infections in Denmark
  Contact: Lykke Larsen, MD
Department of Neurosurgery, Odense University Hospital
Odense, Region Syd 5000
1 trial
- NCT03948256Danish RAndomized Trial of External Ventricular Drainage Cessation IN Aneurysmal Subarachnoid Haemorrhage
Department of Orthopaedic Surgery and Traumatology, Odense University Hospital (OUH)
Odense, 5000
1 trial
- NCT04070027Progressive Resistance Training Versus Total Hip Arthroplasty in Patients With Hip Osteoarthritis
Department of Rheumatology, Odense University Hospital
Odense, 5000
1 trial
- NCT07840430Home-based Exercise for Improving Health-related Quality of Life in Systemic Sclerosis
  Contact: Katrine H Gade, MD, Consultant
Department of Surgery, Odense University Hospital
Odense, 5000
1 trial
- NCT06335420Prophylactic Properties of Carrot Juice in Patients With High-Risk Colorectal Polyps
  Contact: Alexandra Agache, postdoc researcher
Dept. of Obstetrics and Gynaecology, Odense University Hospital
Odense, 5000
1 trial
- NCT05678543Danish Diabetes Birth Registry 2
  Contact: Dorte M Jensen, Prof.
Dept of otorhinolaryngology, Odense University Hospital
Odense, 5000
1 trial
- NCT07187583Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps
  Contact: Anette Kjeldsen, MD, prof.
Duplicate_Odense Universitets Hospital /ID# 209502
Odense C, Region Syddanmark 5000
1 trial
- NCT03398135A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
Odense Universitets Hospital
Odense, 5000
1 trial
- NCT02950051Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation
Odense Universitets Hospital
Odense C, 4500
1 trial
- NCT05963698The Fourth Left Atrial Appendage Occlusion Study
  Contact: Mikkel Hougaard, MD (principal investigator)
Odense Universitets Hospital (Site 0422)
Odense C, Region Syddanmark 5000
1 trial
- NCT03867084Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
Odense Universitets Hospital (Site 3201)
Odense, Region Syddanmark 5000
1 trial
- NCT03675737Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)
Odense University Hospital, Cardiac Surgery Department
Odense, 5000
1 trial
- NCT06475547Inflammation and Postoperative Atrial Fibrillation in Cardiac Surgery
Odense University Hospital, Deparment of Urology
Odense, 5000
1 trial
- NCT04114825Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer
Odense University Hospital, Department of Endocrinology
Odense, 5000
1 trial
- NCT06509776Skeletal Maturation and Endocrine Health in Young Adults
Odense University Hospital, Department of Haematology
Odense, DK-5000
1 trial
- NCT03580655(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
Odense University Hospital - Department of Respiratory Medicine
Odense C, 5000
1 trial
- NCT04905693Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Odense University Hospital, Dept of Paediatrics
Odense, 5000
1 trial
- NCT03911128A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
  Contact: Trial Central Office
Odense University Hospital - FLASH - Centre for Liver Research
Odense C, 5000
1 trial
- NCT04822181Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Odense University Hospital /ID# 215390
Odense, Region Syddanmark 5000
1 trial
- NCT04379050Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
Odense University Hospital /ID# 252036
Odense, Region Syddanmark 5000
1 trial
- NCT06107426Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease
Odense University Hospital, OUH
Odense, 5000
1 trial
- NCT05972525What Matters to Patients With Severe Hip or Knee Osteoarthritis?
Odense University Hospital (Site 0705)
Odense C, Region Syddanmark 5000
1 trial
- NCT04728893Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
  Contact: Toll Free Number
Odense University Hospital (Site 2101)
Odense, Region Syddanmark 5000
1 trial
- NCT04949256Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).
Pain Center, University Hospital Odense
Odense, Funen 5000
1 trial
- NCT06476392Melatonin fOr CHronic bAck Pain (The MOCHA Trial)
The Department of Cardiothoracic Anaesthesiology, Odense University Hospital
Odense, DK-5000
1 trial
- NCT05895838The Danish Out-of-Hospital Cardiac Arrest Study
Unit for Clinical Alcohol Research, Research Unit of Psychiatry, Odense University Hospital; University of Southern Denmark
Odense
1 trial
- NCT07728968The 15-Mental Project: Implementation and Evaluation of the 15-Mental in a Mental Health Hospital Setting
University Hospital Odense
Odense
1 trial
- NCT05017753Thoracentesis to Alleviate Cardiac Pleural Effusion
University Hospital of Odense
Odense, 5000
1 trial
- NCT01574053Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
  Contact: Stinne Veilstrup Krøigård
Department of Hematology X, Odense University Hospital
Odense
Department of Nephrology, Odense University Hospital
Odense, 5000
Department of Neurology, Odense University Hospital
Odense, 5000
Odense PIPAC Center, Department of Surgery, Odense University Hospital
Odense, 5000
Odense Universitetshospital (OUH) (Odense University Hospital)
Odense, Region Syddanmark 5000
Odense Universitets Hospital (Site 0904)
Odense, Region Syddanmark 9000
Odense Universitets Hospital (Site 1000)
Odense, Region Syddanmark 5000
Odense University Hospital, Department of Oncology
Odense, 5000
Odense University Hospital - Department of Respiratory Medicine J.
Odense C, 5000
Odense University Hospital - Hematology
Odense, DK-5000 C
Odense University Hospital /ID# 155531
Odense, Region Syddanmark 5000
Odense University Hospital /ID# 164417
Odense, Region Syddanmark 5000
Odense University Hospital /ID# 223217
Odense, Region Syddanmark 5000
Odense University Hospital /ID# 226593
Odense, Region Syddanmark 5000
Odense University Hospital /ID# 241663
Odense, Region Syddanmark 5000
Odense University Hospital /ID# 251261
Odense, Region Syddanmark 5000
Odense University Hospital /ID# 260777
Odense, Region Syddanmark 5000
Odense University Hospital /ID# 260924
Odense, Region Syddanmark 5000
Odense University Hospital /ID# 267778
Odense, Region Syddanmark 5000
Odense University Hospital /ID# 274970
Odense C, Region Syddanmark 5000
Odense University Hospital /ID# 276462
Odense, Region Syddanmark 5000
Odense University Hospital | Odense - Endocrinology Department
Odense, Region of Southern Denmark / Region Syddanmark 5000
Odense University Hospital (Site 1701)
Odense, Region Syddanmark 5000

Conditions

Diseases this institution publishes on or runs trials for.

Type 2 diabetes76 works · 11 trials
Colorectal cancer57 works · 32 trials
Crohn's disease29 works · 17 trials
Multiple myeloma27 works · 37 trials
Ulcerative colitis22 works · 11 trials
Gestational diabetes20 works · 2 trials
Aortic stenosis18 works · 7 trials
Aortic aneurysm16 works · 0 trials
Diffuse large B-cell lymphoma10 works · 6 trials
Fibromyalgia6 works · 0 trials
Coeliac disease6 works · 0 trials
Neuromyelitis optica (NMOSD)5 works · 0 trials
Follicular lymphoma5 works · 7 trials
Immune thrombocytopenia (ITP)4 works · 1 trial
Polymyalgia rheumatica4 works · 4 trials
Giant cell arteritis4 works · 3 trials

Institution data: ROR 00ey0ed83 (CC0-1.0)Updated 14 Nov 2026

Report an error